San Francisco, California — According to state and local economic development sources Janssen Pharmaceutical Companies plans to expand in San Francisco. The company plans to occupy the new space in San Francisco, on or about January 1, 2022. According to the company website at Janssen more than 35,000 are working hard to treat, cure, stop and prevent some of the most devastating and complex diseases of our time – from heart disease, diabetes, and psoriasis to Alzheimer’s, HIV, and cancer. We believe that challenging something is the best way to change it. So, every day, in more than 150 countries, we bring together cutting-edge science and the most creative minds in the industry to think differently about how diseases are treated and prevented. We aim not only to innovate but also to empower people with the tools they need to make informed decisions and achieve the best possible results for their health.

To learn more about Janssen Pharmaceutical Companies, visit http://www.janssen.com/

Company Contact:
Mathai Mammen, Global Head of R&D
https://www.linkedin.com/in/mathai-mammen-0238371/
908-218-6095

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved